Development of a highly potent and selective degrader of LRRK2 (2023)
Attributed to:
Understanding Signalling Pathways Mutated in Inherited Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2023.129449
Publication URI: http://dx.doi.org/10.1016/j.bmcl.2023.129449
Type: Journal Article/Review
Parent Publication: Bioorganic & Medicinal Chemistry Letters